Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
NOLVADEX
Generic name / active ingredient
tamoxifen
Dosage-form class
Japan PMDA current label: tamoxifen citrate film-coated oral tablets, with tamoxifen 10 mg or 20 mg per tablet.
Route
Oral
Record reviewed
2026-08-26

Copy from the pack in hand

Source-linked reading points

  • Check the full NOLVADEX/ノルバデックス name, generic tamoxifen, 10 mg or 20 mg per tablet, film-coated oral-tablet form, target market and current prescription together. mg is a labelled amount for an exact tablet, not a web calculation for an individual's tablet count, duration or conversion between strengths.
  • ノルバデックス and ノルバスク (NORVASC) differ by only a small amount of text; a partial sound, colour or the fact that both are tablets cannot establish that they are the same medicine. If the name, pack, market or strength is unclear, check the full trade name, generic name, strength, form and accessible source document, and have a pharmacist or prescriber review the actual pack and complete medicine list.
  • A patient medicine guide helps patients and families understand a medicine and recognise possible serious adverse reactions early; it does not replace a prescription, treatment team or individual risk assessment. Pregnancy/possible pregnancy, breast-feeding, history, other prescription medicines, OTC products and supplements require item-by-item review by the responsible team before actual use.
  • With breathing difficulty, swelling of the face or throat, chest pain, sudden one-sided limb swelling/pain, sudden neurologic change or another acute serious concern, prioritise local emergency medical support; do not test the cause by stopping or changing several medicines yourself.

Reviewed presentation examples — compare every field

  • Tamoxifen 10 mg per tablet; product identity listed in the current PMDA labelJapan approval No. 21800AMX10347
  • Tamoxifen 20 mg per tablet; product identity listed in the current PMDA labelJapan approval No. 21800AMX10348

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-26
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image